Cargando…

Intravenous thrombolysis in Chinese patients with mild acute ischemic stroke

BACKGROUND: Mild stroke accounts for more than a half of all stroke patients, and short-term outcomes after treatment with intravenous (IV) recombinant tissue plasminogen activator (rtPA) have not been fully investigated in this group. METHODS: Our study investigated short-term outcomes and predicto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Yunyun, Yan, Ran, Gu, Hongqiu, Wang, Shang, Fisher, Marc, Zhao, Xingquan, Yang, Xin, Wang, Chunjuan, Qi, Zhou, Meng, Xia, Li, Zixiao, Wang, Yongjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246215/ https://www.ncbi.nlm.nih.gov/pubmed/34268380 http://dx.doi.org/10.21037/atm-21-40

Ejemplares similares

Intravenous Thrombolysis in Chinese Patients with Different Subtype of Mild Stroke: Thrombolysis in Patients with Mild Stroke
por: Chen, Weiqi, et al.
Publicado: (2017)

Intravenous thrombolysis versus antiplatelet therapy in minor stroke patients with large vessel occlusion
por: Duan, Chunmiao, et al.
Publicado: (2023)

Outcomes in minor stroke patients treated with intravenous thrombolysis
por: Duan, Chunmiao, et al.
Publicado: (2023)

Clinical Significance and Dynamic Change of Coagulation Parameters in Ischemic Stroke Patients Treated with Intravenous Thrombolysis
por: Li, Guangshuo, et al.
Publicado: (2022)

Clinical Significance of Stress Hyperglycemic Ratio and Glycemic Gap in Ischemic Stroke Patients Treated with Intravenous Thrombolysis
por: Li, Guangshuo, et al.
Publicado: (2022)

Predictors of dysphagia screening and pneumonia among patients with acute ischaemic stroke in China: findings from the Chinese Stroke Center Alliance (CSCA)
por: Liang, Jianshu, et al.
Publicado: (2022)

Intravenous thrombolysis is more safe and effective for posterior circulation stroke: Data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
por: Tong, Xu, et al.
Publicado: (2016)

Association Between Neutrophil-to-Lymphocyte Ratio/Lymphocyte-to-Monocyte Ratio and In-Hospital Clinical Outcomes in Ischemic Stroke Treated with Intravenous Thrombolysis
por: Li, Guangshuo, et al.
Publicado: (2022)

Revisiting the Smoking Paradox in Acute Ischemic Stroke Patients: Findings From the Chinese Stroke Center Alliance Study
por: Hu, Guoliang, et al.
Publicado: (2023)

Intravenous thrombolysis for acute ischemic stroke during two COVID-19 outbreaks in China: Wuhan pandemic and Beijing pandemic
por: Li, Guangshuo, et al.
Publicado: (2023)

Prevalence and In-hospital outcomes of diabetes among acute ischemic stroke patients in china: results from the Chinese Stroke Center Alliance
por: Hu, Guoliang, et al.
Publicado: (2022)

In-hospital clinical outcomes in diffusion weighted imaging-negative stroke treated with intravenous thrombolysis
por: Li, Guangshuo, et al.
Publicado: (2022)

Stress hyperglycemia is associated with in‐hospital mortality in patients with diabetes and acute ischemic stroke
por: Mi, Donghua, et al.
Publicado: (2022)

What predicts large vessel occlusion in mild stroke patients?
por: Lu, Zhengzhao, et al.
Publicado: (2023)

GRP per capita and hospital characteristics associated with intravenous tissue plasminogen activator adherence rate: evidence from the Chinese Stroke Center Alliance
por: Zheng, Suxi, et al.
Publicado: (2021)

Cost-Effectiveness of Thrombolysis within 4.5 Hours of Acute Ischemic Stroke in China
por: Pan, Yuesong, et al.
Publicado: (2014)

Characteristics and Outcomes of Intravenous Thrombolysis in Mild Ischemic Stroke Patients
por: Tang, Huan, et al.
Publicado: (2021)

Chinese neurologists’ perspective on intravenous thrombolysis for acute ischemic stroke
por: Wang, Meng‐Die, et al.
Publicado: (2017)

Insulin resistance estimated by estimated glucose disposal rate predicts outcomes in acute ischemic stroke patients
por: Lu, Zhengzhao, et al.
Publicado: (2023)

Prior statin and short‐term outcomes of primary intracerebral hemorrhage: From a large‐scale nationwide longitudinal registry
por: Li, Guangshuo, et al.
Publicado: (2022)

Higher fasting blood glucose was associated with worse in‐hospital clinical outcomes in patients with primary intracerebral hemorrhage: From a large‐scale nationwide longitudinal registry
por: Li, Guangshuo, et al.
Publicado: (2022)

Early neurological deterioration in acute ischemic stroke patients after intravenous thrombolysis with alteplase predicts poor 3-month functional prognosis - data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
por: Che, Fengli, et al.
Publicado: (2022)

Correction: Early neurological deterioration in acute ischemic stroke patients after intravenous thrombolysis with alteplase predicts poor 3-month functional prognosis - data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
por: Che, Fengli, et al.
Publicado: (2022)

Association of sex and age with in‐hospital mortality and complications of patients with intracerebral hemorrhage: A study from the Chinese Stroke Center Alliance
por: Lu, Ping, et al.
Publicado: (2022)

Dysphagia Management and Outcomes in Elderly Stroke Patients with Malnutrition Risk: Results from Chinese Stroke Center Alliance
por: Zhang, Guitao, et al.
Publicado: (2022)

Chinese Stroke Center Alliance: a national effort to improve healthcare quality for acute stroke and transient ischaemic attack: rationale, design and preliminary findings
por: Wang, Yongjun, et al.
Publicado: (2018)

Benefit and risk of early intravenous heparin after thrombolysis in patients with acute ischemic stroke
por: Tong, Xu, et al.
Publicado: (2020)

The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke
por: Dong, Qiang, et al.
Publicado: (2017)

Homocysteine and Clinical Outcomes in Intracerebral Hemorrhage Patients: Results from the China Stroke Center Alliance
por: Wang, Dandan, et al.
Publicado: (2022)

Rationale and design of Patient-centered Retrospective Observation of Guideline-Recommended Execution for Stroke Sufferers in China: China PROGRESS
por: Li, Zixiao, et al.
Publicado: (2019)

Thirteen‐year trends in risk scores predictive values for subsequent stroke in patients with acute ischemic event
por: Xiong, Yunyun, et al.
Publicado: (2023)

Tenecteplase in Ischemic Stroke: Challenge and Opportunity
por: Li, Guangshuo, et al.
Publicado: (2022)

Predictive effect of triglyceride-glucose index on clinical events in patients with acute ischemic stroke and type 2 diabetes mellitus
por: Liu, Dong, et al.
Publicado: (2022)

Intravenous thrombolysis for acute ischemic stroke with extended time window
por: Jia, Xue, et al.
Publicado: (2021)

Body mass index and clinical outcomes in patients with intracerebral haemorrhage: results from the China Stroke Center Alliance
por: Cao, Zhentang, et al.
Publicado: (2021)

Atrial fibrillation is not uncommon among patients with ischemic stroke and transient ischemic stroke in China
por: Yang, Xiaomeng, et al.
Publicado: (2017)

Concurrency of Early-Age Exposure to Chinese Famine and Diabetes Increases Recurrence of Ischemic Stroke
por: Suo, Yue, et al.
Publicado: (2021)

Effect of sex differences on prognosis of intravenous thrombolysis: data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
por: Zhou, Hongyu, et al.
Publicado: (2020)

Intravenous Thrombolysis in Ischemic Stroke Patients With Active Cancer
por: Selvik, Henriette Aurora, et al.
Publicado: (2018)

Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
por: Nam, Ki-Woong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_etnhhemfdousjoc2c6gufp43i7